Profile data is unavailable for this security.
About the company
IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
- Revenue in USD (TTM)0.00
- Net income in USD-5.63m
- Incorporated2018
- Employees2.00
- LocationIMAC Holdings Inc3401 MALLORY LANE, SUITE 100FRANKLIN 37067United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://imacregeneration.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPO Global Inc | 838.00k | -540.00k | 617.35k | 2.00 | -- | -- | -- | 0.7367 | -85.99 | -85.99 | 131.76 | -476.56 | 1.76 | -- | -- | -- | -113.56 | -305.39 | -- | -- | 31.15 | 27.31 | -64.44 | -384.85 | -- | -1.45 | -- | -- | -17.09 | -15.13 | 13.03 | -- | -- | -- |
| China Health Management Corp. | 483.00k | -25.60m | 795.23k | 56.00 | -- | -- | -- | 1.65 | -1,378.45 | -1,378.45 | 25.37 | -41.35 | 0.0425 | 1.16 | 1.49 | 8,625.00 | -190.82 | -- | -395.01 | -- | -2,014.49 | -- | -4,486.13 | -- | 0.0203 | -1,353.25 | -- | -- | 37.69 | -- | -363.55 | -- | -- | -- |
| Mitesco Inc | 6.00k | -4.15m | 909.28k | 3.00 | -- | -- | -- | 151.55 | -0.6434 | -0.6121 | 0.0004 | -2.54 | 0.0332 | -- | -- | 2,000.00 | -1,094.48 | -246.54 | -- | -- | 0.00 | -- | -33,009.50 | -29,214.62 | -- | -0.7877 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
| QHSLab Inc | 1.61m | -190.50k | 1.03m | 4.00 | -- | -- | -- | 0.6396 | -0.0199 | -0.0199 | 0.1649 | -0.0367 | 0.9097 | 31.80 | 13.83 | 403,272.50 | -10.74 | -51.17 | -- | -197.31 | 59.52 | -- | -11.81 | -65.10 | 0.1152 | -0.264 | 1.30 | -- | 13.34 | -- | 52.98 | -- | -- | -- |
| IMAC Holdings Inc | 0.00 | -5.63m | 2.38m | 2.00 | -- | -- | -- | -- | -5.04 | -5.46 | 0.00 | -1.08 | 0.00 | -- | 0.00 | 0.00 | -166.65 | -48.88 | -1,050.71 | -70.25 | -- | -- | -- | -97.63 | -- | -14.97 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
| Avalon Globocare Corp | 1.30m | -14.54m | 3.33m | 5.00 | -- | -- | -- | 2.57 | -1.32 | -1.32 | 0.1176 | 0.3839 | 0.0517 | -- | 11.49 | 259,018.00 | -58.06 | -100.94 | -81.85 | -134.51 | 17.21 | 24.44 | -1,122.68 | -1,011.06 | -- | -0.4168 | 0.6497 | -- | 4.45 | -4.28 | -40.03 | -- | -51.83 | -- |
| Medical Care Technologies Inc. | 0.00 | -1.07m | 3.64m | 0.00 | -- | -- | -- | -- | -553,570.10 | -553,570.10 | 0.00 | -389.23 | 0.00 | -- | -- | -- | -154.94 | -- | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -40.06 | -- | -- | -- |
| Modern Mobility Aids Inc | 0.00 | -1.59m | 4.58m | -- | -- | -- | -- | -- | -0.0177 | -0.0177 | 0.00 | -0.004 | 0.00 | -- | -- | -- | -4,668.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -371.94 | -- | -- | -- |
| Syra Health Corp | 7.07m | -4.19m | 4.69m | 78.00 | -- | 1.51 | -- | 0.6631 | -0.6709 | -0.6709 | 1.19 | 0.3169 | 2.81 | -- | 11.27 | 90,635.38 | -166.37 | -- | -287.17 | -- | 23.56 | -- | -59.23 | -- | -- | -177.32 | 0.0518 | -- | -1.83 | -- | -38.72 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Kestra Advisory Services LLCas of 30 Jun 2024 | 44.40k | 2.58% |
| Walleye Capital LLCas of 30 Jun 2024 | 13.83k | 0.80% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 8.20k | 0.48% |
| UBS Securities LLCas of 30 Jun 2024 | 4.92k | 0.29% |
| Tower Research Capital LLCas of 30 Jun 2024 | 3.72k | 0.22% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 167.00 | 0.01% |
| Newbridge Financial Services Group, Inc.as of 30 Jun 2024 | 167.00 | 0.01% |
| Financial Perspectives, Inc.as of 30 Jun 2024 | 20.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Jun 2024 | 8.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 30 Jun 2024 | 0.00 | 0.00% |
